Zobrazeno 1 - 10
of 60
pro vyhledávání: '"W Z, Potter"'
Autor:
G Muscettola, J M Griffiths, T Kapitany, Cyril Höschl, J A Swinkels, P Fischer, C A Zarate, Guy M. Goodwin, Stanislaw Puzynski, M Gastpar, L Conti, U F Malt, Willem A. Nolen, W Z Potter, M L Bourgeois, G N Papadimitriou
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 1:S9-S12
(1997). Treatment of bipolar depressive mood disorders: Algorithms for pharmacotherapy. International Journal of Psychiatry in Clinical Practice: Vol. 1, No. sup1, pp. S9-S12.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5c09a1566f3394e72fe6d27fa60c1ce
https://doi.org/10.3109/13651509709024750
https://doi.org/10.3109/13651509709024750
Autor:
W Z Potter, H K Manji
Publikováno v:
Clinical Chemistry. 40:279-287
Despite extensive research, the biochemical abnormalities underlying the predisposition to and the pathogenesis of affective disorders remain to be clearly established. Efforts to study norepinephrine (NE) output and function have utilized biochemica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6b775a4cf397c6607d759640fef354a
https://doi.org/10.1093/clinchem/40.2.279
https://doi.org/10.1093/clinchem/40.2.279
Autor:
Rachelle S. Doody, Lon S. Schneider, David P. Salmon, Bruno Dubois, Maria C. Carrillo, Zaven S. Khachaturian, R. G. Thomas, S. Andrieu, Howard Feldman, W. Z. Potter, Michael C. Donohue, J. Touchon, M Bednar, Eric Siemers, Eric Salmon, Bruno Vellas, Cristina Sampaio, Paul S. Aisen, Ronald C. Petersen, Rachel Schindler, Michael Grundman, Suzanne Hendrix
Background: A large number of promising candidate disease-modifying treatments for Alzheimer disease (AD) continue to advance into phase II and phase III testing. However, most completed trials have failed to demonstrate efficacy, and there is growin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e56f2a157327a10e1674aedea39c4cd
https://europepmc.org/articles/PMC3034393/
https://europepmc.org/articles/PMC3034393/
Autor:
W. Z. Potter
Publikováno v:
The journal of nutrition, health & aging. 14:310-311
To test the hypothesis that excess amyloid deposition is an essential step in the pathophysiology of Alzheimer's disease appropriate biomarkers are essential in selecting agents that modify amyloid formation or clearance. Cerebrospinal fluid concentr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::660f892c4eaeaeec86d4890aceb36960
https://doi.org/10.1007/s12603-010-0070-5
https://doi.org/10.1007/s12603-010-0070-5
Autor:
M V, Rudorfer, W Z, Potter
Publikováno v:
Cellular and molecular neurobiology. 19(3)
1. Despite the considerable advances in the treatments available for mood disorders over the past generation, tricyclic antidepressants (TCAs) remain an important option for the pharmacotherapy of depression. 2. The pharmacokinetics of TCAs are chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da34db52b3749b153321bbbfa7b0a793
https://pubmed.ncbi.nlm.nih.gov/10319193
https://pubmed.ncbi.nlm.nih.gov/10319193
Autor:
W Z, Potter
Publikováno v:
The Journal of clinical psychiatry. 59
From the perspective of pharmacologic treatment, bipolar depression is considered in this article as belonging to a spectrum of affective disorders. Insufficient controlled data permit only general recommendations for treatment of the spectrum of aff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db82fa11c4da4b67b5915b5aa097fe30
https://pubmed.ncbi.nlm.nih.gov/9840196
https://pubmed.ncbi.nlm.nih.gov/9840196
Publikováno v:
Psychopharmacology bulletin. 34(1)
The implementation of a multisite, randomized, clinical psychopharmacologic trial involves a substantial investment of time and effort on the part of all participants. Because of their complexity, such clinical trials present unique methodological an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3a3ddbfd64b8fe43c0d760552a94fcc5
https://pubmed.ncbi.nlm.nih.gov/9564194
https://pubmed.ncbi.nlm.nih.gov/9564194
Autor:
W Z, Potter, M E, Schmidt
Publikováno v:
Modern problems of pharmacopsychiatry. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1b2026314b6b0bfb54736802f1376953
https://pubmed.ncbi.nlm.nih.gov/9344366
https://pubmed.ncbi.nlm.nih.gov/9344366
Publikováno v:
Psychopharmacology bulletin. 33(2)
The sympathetic nervous system can modulate glucose levels through a variety of mechanisms, including inhibition of insulin release by alpha2-adrenergic receptors. Such effects could potentially confound measurements of brain glucose metabolism durin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27dea9717a18cb98e5cab95f903d43fe
https://pubmed.ncbi.nlm.nih.gov/9230639
https://pubmed.ncbi.nlm.nih.gov/9230639
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(7)
The reliability of serial [18F]fluorodeoxyglucose (FDG) PET scans for psychopharmacologic studies was tested by using placebo infusions.FDG scans were obtained before and after a 30 min placebo infusion (n = 10; Group 1) or after each of two bolus in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3e04c06e0272bf312c005456bc1725b
https://pubmed.ncbi.nlm.nih.gov/8965185
https://pubmed.ncbi.nlm.nih.gov/8965185